All peptide synthesis reagents and amino acid derivatives were purchased from GL Biochem (Shanghai) and Novabiochem; amino acids were purchased as protected Fmoc amino acids with the standard side chain protecting scheme: Fmoc-Ala-OH, Fmoc-Leu-OH, Fmoc-Lys(Boc)-OH, Fmoc-Ser(t-Bu)-OH, Fmoc-Glu(Ot-Bu)-OH, Fmoc-Trp(Boc)-OH, Fmoc-Asn(Trt)-OH, FmocIle-OH, Fmoc-Thr(t-Bu)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-His(Trt)-OH and Fmoc-Asp(Ot-Bu)-OH except for the orthogonally protected Fmoc-Lys(Alloc)-OH, which was purchased from Bachem. All other chemicals were purchased from Aldrich or Fluka. All solvents were dry and synthesis grade, unless specifically noted.
Coupling of bromoacetic acid:
The resin containing the peptide (50 mg, aprox. 0.01 mmol) was suspended in dichloromethane (DCM) and shaken for 1 h to ensure a good swelling. On the other hand, bromoacetic acid (28 mg, 20 equiv) was dissolved in 630 µL CH 2 Cl 2 and cooled to 0 ºC. Diisopropylcarbodiimide (DIC, 16 µL, 10 equiv) was added, and the mixture stirred at 0 ºC for 20 min. The solid was filtered off and the flitrate was added over the resin. The suspension was shaken for 30 min. The resin was then filtered and washed with DCM.
For TMR-br and TMR-brH, after the N-terminal aminoacid, we coupled 5-(Fmoc-amino)valeric acid as spacer between the peptide and the fluorophore, and finally TMR fluorophore: 5(6)-carboxytetramethylrhodamine was coupled using 3 equiv of the rhodamine (0.15 mmol, 64.5 mg), 3 equiv of HATU and 5 equiv of DIEA 0.2 M in DMF for 60 min.
The cleavage/deprotection step was performed by treatment of the resin-bound peptide for 1.5-2h with the following cleavage cocktails: 940 µL TFA, 25 µL EDT, 25 µL H 2 O and 10 µL TIS (1 mL of cocktail / 40 mg resin) for cysteine-containing peptides and 900 µL TFA, 50 µL CH 2 Cl 2 , 25 µL H 2 O and 25 µL TIS (1 mL of cocktail / 40 mg resin) for the rest.
The crude products were purified by RP−HPLC, 4 mL/min, gradient 10 to 50% B over 40 min. (A: H 2 O 0.1% TFA, B: CH 3 CN 0.1% TFA) and identified as the desired peptides.
High-Performance Liquid Chromatography (HPLC) was performed using an Agilent 1100 series Liquid Chromatograph Mass Spectrometer system. Analytical HPLC was carried out using a Eclipse XDB-C18 analytical column (4.6 x 150 mm, 5 µm), 1 mL/min, gradient 5 to 75% B over 30 min. Purification of the peptides was performed on a semipreparative Phenomenex Luna-C18 (250 × 10 mm) reverse-phase column.
Electrospray Ionization Mass Spectrometry (ESI/MS) was performed with an Agilent 1100 Series LC/MSD VL G1956A model in positive scan mode. (SH)GAGA was isolated with an approx. yield of 17%. AT-Hook-Br was isolated with an approx. yield of 19%. Coupling of (SH)GAGA and AT-hook-Br:
(SH)GAGA (0.1 mg, 3x10 -5 mmol) was dissolved in desoxygenated phosphate buffer (130 µL, 10 mM, pH = 7.5). A ZnSO 4 solution (4.5x10 -5 mmol, 9 µL of a 5 mM solution in Milli-Q water, 1.5 equiv) was added, and the mixture was stirred at room temperature for 10 minutes under argon atmosphere. AT-Hook-Br (6x10 -5 mmol, 5 µL of a 12 mM solution in desoxygenated phosphate buffer, 2 equiv) was added, and the solution was stirred again at room temperature for 1 hour under argon atmosphere. 
Superpositions
This was carried out with MacPymol using the references PDB ID: 1YSA for GCN4, 3UXW for AT-Hook and 1YUI for GAGA.
Fig. S7
Model of the simultaneous interaction of: Left) br (green) and AT-Hook; Right) (SH)GAGA (orange) and AT-Hook.
Oligonucleotide sequence
Double stranded (only one strand is shown) oligonucleotides used for EMSA experiments with conjugates brH and GAGAH were supplied by Thermo Fischer and their sequences were: 
EMSA experiments
EMSAs were performed with a BioRad Mini Protean gel system, powered by an electrophoresis power supplies PowerPac Basic model, maximum power 150 V, frequency 50-60 Hz at 140 V (constant V). Binding reactions were performed over 30 min in 18 mM Tris (pH 7.5), 90 mM KCl, 1.8 mM MgCl 2 , 1.8 mM EDTA, 9% glicerol, 0.11 mg/mL BSA and 2.2% de NP-40 for brH, and 18 mM Tris-HCl (pH 7.5), 90 mM KCl, 1.8 mM MgCl 2 , 0.2 mM TCEP, 9% glycerol, 0.11 mg/mL BSA, 2.2% NP--40 and 0.02 mM of ZnCl 2 for GAGAH. In the experiments we used 75 nM of the ds−DNAs and a total incubation volume of 20 uL. After incubation for 30 min products were resolved by PAGE using a 10% non--denaturing polyacrylamide gel and 0.5x TBE buffer for 40 min at 20 ºC, and analyzed by staining with SyBrGold (Molecular Probes: 5 µL in 50 mL of 1x TBE) for 10 min. and visualized by fluorescence. TMR-AT•GAGA (TMR-5´-CGCGTCATAATTGAGAGCGC-3´, one strand shown) (5µL, 5 µM) was added to 995 µL of Tris-HCl buffer 20 mM pH 7.5, 100 mM NaCl, 0.02 mM of ZnCl 2 , and the anisotropy was measured. Aliquots of a stock solution in water of brH or GAGAH (12.5 µM) were successively added to this solution, and the anisotropic value was recorded after each addition.
In the case of GAGAH, we also made the experiment in the presence of calf thymus DNA (50 µM in base pairs). CD measurements were made with a Jasco-715 coupled with a thermostat Nestlab RTE-111. The settings used were: Acquisition range: 300-195nm; band width: 2.0 nm; resolution: 0.2 nm; accumulation: 5 scans; sensitivity 10 mdeg; response time: 0.25 s, speed: 100 nm/min. Measurements were made in a 2 mm cell at 20 ºC. Samples contained 10 mM phosphate buffer pH 7.5 and 100 mM of NaCl, 5 µM peptide and 5 µM of corresponding dsDNA (when present). The mixtures were incubated for 5 min before registering. The CD spectra of the peptide (when measured in the presence of DNA) was calculated as the difference between the spectrum of the peptide/DNA mixture and the measured spectrum of a sample of the DNA oligonucleotide. The spectra are the average of 5 scans and were processed using the "smooth" macro implemented in the program Kaleidagraph (v 3.5 by Synergy Software).
Cellular internalization studies
Cells growing on glass coverslips were incubated in PBS containing 5 µM of TMR-br or TMRbrH for 30 min. Then they were washed twice with PBS and observed in vivo in a fluorescence microscope equipped with adequate filters and differential interference contrast (DIC) microscopy. Digital pictures of the different samples were taken under identical conditions of gain and exposure.
The assay was carried with three different cell lines: monkey Vero cells, A549 human lung carcinoma cells and HeLa cells.
. 
